[Expert recommendations on the use of teduglutide in pediatric patients with short bowel syndrome].

{"article_title":"[Expert recommendations on the use of teduglutide in pediatric patients with short bowel syndrome].","author":"Mart\u00ednez MI, Balacco M, Busoni V, Fern\u00e1ndez A, Rumbo C","journal_title":"Medicina","issn":"1669-9106","isbn":"","publication_date":"2021 Aug","volume":"83","issue":"1","first_page":"114","page_count":"","accession_number":"36774605","doi":"","publisher":"Fundacio\u0301n Revista Medicina (Buenos Aires)","doctype":"English Abstract","subjects":"Short Bowel Syndrome drug therapy; Glucagon-Like Peptides analogs & derivatives; Child; Humans; Glucagon-Like Peptide 2 adverse effects; Peptides therapeutic use","interest_area":["Pediatric Medicine"," Gastroenterology"," Internal Medicine"],"abstract":"Short bowel syndrome is a low-incidence disorder among pediatric patients, but it is associated with high morbidity and mortality rates. Management of these patients by an interdisciplinary team of experts focused on intestinal rehabilitation improves short- and long-term outcomes. Available resources for treatment include teduglutide, a glucagon-like peptide type 2 (GLP-2) analog made by recombinant techniques. Considering the available evidence and the authors' experience, Delphi-based recommendations for the use of teduglutide are suggested for healthcare professionals who treat pediatric patients with short bowel syndrome, as well as for health authorities.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=36774605&authtype=shib&custid=ns346513&group=main&profile=eds","isPdfLink":true,"isSAML":false,"additionalInfo":{"Authored_By":"Mart\u00ednez MI, Balacco M, Busoni V, Fern\u00e1ndez A, Rumbo C","Journal_Info":"Publisher: Fundacio\u0301n Revista Medicina (Buenos Aires) Country of Publication: Argentina NLM ID: 0204271 Publication Model: Print Cited Medium: Internet ISSN: 1669-9106 (Electronic) Linking ISSN: 00257680 NLM ISO Abbreviation: Medicina (B Aires) Subsets: MEDLINE","Publication_Type":"English Abstract; Guideline","Published_Date":"2023-01-01","Source":"Medicina [Medicina (B Aires)] 2023; Vol. 83 (1), pp. 114-121.","Languages":"Spanish; Castilian","Electronic_ISSN":"1669-9106","MeSH_Terms":"Short Bowel Syndrome*\/drug therapy , Glucagon-Like Peptides*\/analogs & derivatives, Child ; Humans ; Glucagon-Like Peptide 2\/adverse effects ; Peptides\/therapeutic use","Subjects":"Child, Humans, Glucagon-Like Peptide 2 adverse effects, Peptides therapeutic use, Short Bowel Syndrome drug therapy, Glucagon-Like Peptides analogs & derivatives","Title_Abbreviations":"Medicina","Volume":"83"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"36774605","RelevancyScore":"944","PubType":"","PubTypeId":"unknown","PreciseRelevancyScore":"943.560180664063"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=36774605&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=36774605&authtype=shib&custid=ns346513&group=main&profile=eds"}